CDK-TCIP1
CDK-TCIP1 is a bivalent molecule linking CDK9 inhibitor SNS-032 to BCL6 ligand BI3812 (HY-111381). CDK-TCIP1 potently and specifically kills BCL6-overexpressing cells with EC50 of 7.7 nM for SUDHL5 cells[1].
Product Specifications
CAS Number
3008612-35-6
UNSPSC
12352005
Target
Bcl-2 Family; CDK
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdk-tcip1.html
Purity
98.86
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC(C)(C1=CN=C(CSC2=CN=C(NC(C3CCN(C(CCCCCCNC(C(CC4)CCN4C5=NC=C(Cl)C(NC6=CC(C=C(OCC(NC)=O)C(N7C)=O)=C7C(OC)=C6)=N5)=O)=O)CC3)=O)S2)O1)C
Molecular Formula
C48H62ClN11O8S2
Molecular Weight
1020.66
References & Citations
[1]Roman C Sarott, et al. Relocalizing transcriptional kinases to activate apoptosis. Science. 2024 Oct 4;386 (6717) :eadl5361.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK9
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Uroplakin 1B (Urothelial Differentiation Marker) (UPK1B/3081), CF488A conjugate, 0.1mg/mL
